SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-119568
Filing Date
2021-04-16
Accepted
2021-04-16 17:16:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 82059
2 GRAPHIC g51356g0416174704588.jpg GRAPHIC 2665
  Complete submission text file 0001193125-21-119568.txt   86802
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)